Literature DB >> 19480746

Pyoderma gangrenosum: common pitfalls in management and a stepwise, evidence-based, therapeutic approach.

Vimal Prajapati1, Jeremy Man, Alain Brassard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19480746     DOI: 10.2310/7750.2009.00002

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


× No keyword cloud information.
  5 in total

1.  Facial superficial granulomatous pyoderma.

Authors:  Sara D'Epiro; Monica Salvi; Carlo Mattozzi; Simona Giancristoforo; Valentina Faina; Laura Macaluso; Cecilia Luci; Teresa Grieco; Stefano Calvieri; Antonio G Richetta
Journal:  Int Wound J       Date:  2013-11-28       Impact factor: 3.315

2.  A case of atypical pyoderma gangrenosum.

Authors:  Ermira Vasili; Entela Shkodrani; Liberta Labinoti; Alert Xhaja
Journal:  J Dermatol Case Rep       Date:  2010-04-11

3.  [Pyoderma gangrenosum after intramedullary nailing of tibial shaft fracture: A differential diagnosis to necrotizing fasciitis].

Authors:  S Hackl; P Merkel; S Hungerer; J Friederichs; N Müller; M Militz; V Bühren
Journal:  Unfallchirurg       Date:  2015-12       Impact factor: 1.000

Review 4.  Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview.

Authors:  Kyla Pagani; Danitza Lukac; Aashni Bhukhan; Jean S McGee
Journal:  Am J Clin Dermatol       Date:  2022-04-20       Impact factor: 6.233

5.  UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial.

Authors:  Fiona F Craig; Kim S Thomas; Eleanor J Mitchell; Hywel C Williams; John Norrie; James M Mason; Anthony D Ormerod
Journal:  Trials       Date:  2012-04-28       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.